These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5296958)

  • 21. Aspects of the natural history of herpes zoster. A follow-up investigation of outpatient material.
    Molin L
    Acta Derm Venereol; 1969; 49(6):569-83. PubMed ID: 4190107
    [No Abstract]   [Full Text] [Related]  

  • 22. Ocular findings in Japanese patients with varicella-zoster virus infection.
    Yoshida M; Hayasaka S; Yamada T; Yanagisawa S; Hayasaka Y; Nakamura N; Mihara M
    Ophthalmologica; 2005; 219(5):272-5. PubMed ID: 16123552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The varicella-zoster virus and multiple sclerosis.
    Ross RT
    J Clin Epidemiol; 1998 Jul; 51(7):533-5. PubMed ID: 9674659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of varicella-zoster virus infections.
    Wharton M
    Infect Dis Clin North Am; 1996 Sep; 10(3):571-81. PubMed ID: 8856352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare costs associated with varicella and herpes zoster in Norway.
    Haugnes H; Flem E; Wisløff T
    Vaccine; 2019 Jun; 37(29):3779-3784. PubMed ID: 31151798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.
    Edgar BL; Galanis E; Kay C; Skowronski D; Naus M; Patrick D
    Can Commun Dis Rep; 2007 Nov; 33(11):1-15. PubMed ID: 18163240
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era.
    Pandya A; Wasfy S; Hébert D; Allen UD
    Pediatr Transplant; 2001 Jun; 5(3):153-9. PubMed ID: 11422816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Herpez zoster in childhood--demonstration of complicated forms].
    Kellerer H; Kerl H
    Klin Padiatr; 1973 Jan; 185(1):57-63. PubMed ID: 4540237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Item 84--Herpesvirus infections in the child and the immunocompetent adult: chickenpox and shingles].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A22-8. PubMed ID: 23176852
    [No Abstract]   [Full Text] [Related]  

  • 36. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect.
    Toyama N; Shiraki K;
    J Dermatol Sci; 2018 Oct; 92(1):89-96. PubMed ID: 30041832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.
    Enders G; Miller E; Cradock-Watson J; Bolley I; Ridehalgh M
    Lancet; 1994 Jun; 343(8912):1548-51. PubMed ID: 7802767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.
    Schuette MC; Hethcote HW
    Bull Math Biol; 1999 Nov; 61(6):1031-64. PubMed ID: 17879870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.